Primary Sclerosing Cholangitis (PSC)

Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.

Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.

PUBLIC PAGE
Sep 9, 2019

Carlos PSC Program Abstracts Accepted for the 2019 Annual AASLD meeting

By Konstantinos N. Lazaridis, M.D. @klazaridis
During the annual AASLD meeting that will take place in Boston, MA (November 8-12, 2019) our group has submitted five scientific abstracts, which have being accepted for presentation. This work ranges from discovery, to translation, and to clinical application. We are very excited to share with our followers this [...]
Carlos PSC Program Abstracts Accepted for the 2019 Annual AASLD meeting
Aug 26, 2019

New therapeutic trials for PSC offered at Mayo Clinic

By Ethan McConkey, Moderator @ethanmcconkey
  Clinical trials are an important aspect of our work as we try to find a medical therapy for patients suffering from Primary Sclerosing Cholangitis (PSC). To this end, we would like to inform the PSC community that Mayo Clinic in Rochester Minnesota is currently recruiting patients with [...]
New therapeutic trials for PSC offered at Mayo Clinic
Aug 12, 2019

4th Annual Carlos PSC External Advisory Committee Meeting

By Ethan McConkey, Moderator @ethanmcconkey
On June 28, 2019 the Extramural Advisory Committee (EAC) of the Carlos Research Program in PSC met in Rochester, Minnesota for our annual scientific retreat. The retreat included updates on our scientific programs, clinical trials, and operational initiatives. The Annual Update of the Carlos PSC Research Program is [...]
4th Annual Carlos PSC External Advisory Committee Meeting
Jul 29, 2019

IBD: A Comorbidity of PSC

By Konstantinos N. Lazaridis, M.D. @klazaridis
  The majority of patients with the PSC have Inflammatory Bowel Disease (IBD). In this presentation, Dr. Laura Raffals, Associate Professor of Medicine, Mayo Clinic College of Medicine provides a comprehensive review of the epidemiology, diagnosis, outcomes and management of IBD among PSC patients. View the [...]
IBD: A Comorbidity of PSC
Jul 15, 2019

PSC and Inflammatory Bowel Disease (IBD): Women’s Health Issues

By Konstantinos N. Lazaridis, M.D. @klazaridis
Female patients with the PSC and inflammatory bowel disease (IBD) have unique health and disease issues to deal with. During the 15th Annual Conference of the “PSC Partners Seeking a Cure”", Dr. Alina Allen, Assistant Professor of Medicine, Mayo Clinic College of Medicine, and Dr. Laura Raffals, Associate [...]
PSC and Inflammatory Bowel Disease (IBD): Women’s Health Issues

Invite Others

Send an email to invite people you know to join the Primary Sclerosing Cholangitis (PSC) page.

We'll include this text in the user's invitation.